Want to see AU:ICR full AI Analyst Report?
Top Page
InteliCare Holdings Limited
(Sydney:ICR)
Select Model
Select Model
Rating:50Neutral
Price Target:
AU$0.02
▲(0.00% Upside)
Action:Reiterated
Date:09/15/26
The score is primarily held back by weak financial performance—ongoing large losses, negative gross profit, and persistent cash burn—despite strong recent revenue growth and an improving balance sheet. Technicals add modest support due to near-oversold conditions and a positive MACD, but the broader trend remains weak. Valuation cannot be meaningfully assessed because P/E and dividend yield are unavailable.
Positive Factors
Revenue Growth
The sharp increase in annual revenue indicates improving commercial traction and a growing customer or contract base. If sustained, this expansion can provide operating scale, broaden market presence, and create a foundation for better margins as fixed costs are spread across a larger revenue base.
Negative Factors
Severe Unprofitability
Negative gross profit means current revenue is not yet covering the direct costs of delivering the business, while losses remain roughly comparable to the revenue base. This indicates that growth is not currently translating into earnings and that substantial margin improvement is required for a durable model.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The sharp increase in annual revenue indicates improving commercial traction and a growing customer or contract base. If sustained, this expansion can provide operating scale, broaden market presence, and create a foundation for better margins as fixed costs are spread across a larger revenue base.
Read all positive factors
InteliCare Holdings Limited (ICR) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$14.31M
Dividend YieldN/A
Average Volume (3M)103.15K
Price to Earnings (P/E)―
Beta (1Y)0.26
Revenue Growth113.42%
EPS Growth29.17%
CountryAU
Employees8
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding715,306,760
10 Day Avg. Volume71,730
30 Day Avg. Volume103,154
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)8.89
Price to Sales (P/S)5.36
P/FCF Ratio-9.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
InteliCare Holdings Limited Business Overview & Revenue Model
Company Description
Operating out of Leederville, Australia, Intelicare Holdings Limited was founded in 2016. The company is dedicated to supplying innovative predictive analytics solutions, delivered as a combined hardware and software package, primarily serving Aus...
InteliCare Holdings Limited Financial Statement Overview
Summary
Income Statement
14
Very Negative
Balance Sheet
33
Negative
Cash Flow
18
Very Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.04M | 956.74K | 280.29K | 404.35K | 429.85K |
| Gross Profit | -1.12M | -1.09M | -1.79M | -2.69M | -2.75M |
| EBITDA | -2.45M | -2.07M | -3.02M | -2.89M | -3.78M |
| Net Income | -2.10M | -2.24M | -2.26M | -3.00M | -3.93M |
Balance Sheet | |||||
| Total Assets | 3.34M | 1.02M | 1.52M | 2.48M | 2.88M |
| Cash, Cash Equivalents and Short-Term Investments | 2.73M | 410.53K | 834.20K | 1.94M | 2.27M |
| Total Debt | 524.82K | 716.62K | 612.39K | 726.57K | 18.25K |
| Total Liabilities | 2.11M | 1.86M | 1.69M | 1.53M | 1.34M |
| Stockholders Equity | 1.23M | -833.17K | -168.32K | 949.11K | 1.54M |
Cash Flow | |||||
| Free Cash Flow | -1.19M | -1.67M | -1.66M | -3.11M | -3.14M |
| Operating Cash Flow | -1.18M | -1.67M | -1.66M | -3.10M | -3.10M |
| Investing Cash Flow | -3.81K | -7.09K | 0.00 | -14.35K | -32.92K |
| Financing Cash Flow | 3.51M | 1.25M | 555.65K | 2.78M | 2.73M |
InteliCare Holdings Limited Technical Analysis
Negative
0.02
Price Trends
0.02
Negative
0.02
Negative
0.02
Negative
Market Momentum
>-0.01
Negative
30.69
Neutral
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ICR, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 30.69 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:ICR.
InteliCare Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | AU$155.23M | 67.65 | 2.53% | ― | 26.61% | 41.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | AU$14.31M | -5.88 | -416.53% | ― | 113.42% | 29.17% | |
48 Neutral | AU$117.49M | -6.87 | -203.69% | ― | -1.53% | 28.29% | |
48 Neutral | AU$38.50M | 16.04 | 90.90% | ― | 5.35% | ― | |
45 Neutral | AU$20.97M | -1.13 | -58.13% | ― | 2.08% | -195.31% | |
40 Underperform | AU$14.65M | -1.61 | -1688.04% | ― | 11.45% | 0.69% |
* Healthcare Sector Average
AU:ICR
InteliCare Holdings Limited
0.02
>-0.01
-4.76%
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
0.14
-0.05
-26.32%
AU:BMT
Beamtree Holdings Ltd
0.07
-0.13
-64.50%
AU:ALC
Alcidion Group Limited
0.12
0.03
27.78%
AU:PCK
PainChek Ltd
0.07
-0.39
-84.78%
AU:DOC
Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh
0.11
-0.05
-32.26%
InteliCare Holdings Limited Corporate Events
InteliCare expands aged care deployments and builds SaaS revenue base
Oct 30, 2026
InteliCare used the September 2026 quarter to deepen deployments with existing partners mecwacare, Hardi Aged Care and Warrigal Care, concentrating on residential aged care rollouts and preparing its first retirement living deployment. The company...
InteliCare Posts Quarterly Cash Outflow Amid Stable Customer Receipts
Oct 30, 2026
InteliCare reported customer receipts of A$408,000 for the quarter ended 30 September 2026, reflecting ongoing commercial activity in its smart care and monitoring solutions.Operating cash outflows totalled A$1.27 million, driven by product manufa...
InteliCare Sets 2026 AGM to Review Reports and Board Composition
Oct 13, 2026
InteliCare Holdings Limited has called its 2026 Annual General Meeting for 10.00am AWST on 25 November 2026 in Leederville, Western Australia, setting Monday 23 November 2026 as the record date for shareholder voting eligibility. The notice confir...
InteliCare Files 2026 Annual Report and Confirms ASX Compliance
Oct 13, 2026
InteliCare Holdings Limited released its annual report for the year ended 30 June 2026, detailing its corporate structure, governance arrangements and key professional advisers. The document confirms the company’s continued ASX listing, outl...
InteliCare lodges updated ASX corporate governance statement for FY26
Oct 13, 2026
InteliCare Holdings has released its latest corporate governance statement for the financial year ended 30 June 2026, confirming it is available via the investor section of the company’s website. The statement, approved by the board as at 14...
InteliCare Sets 2026 AGM Date and Director Nomination Deadline
Sep 29, 2026
InteliCare Holdings Ltd, an Australian technology firm, develops predictive analytics systems integrating smart sensors and artificial intelligence to support aged care and health providers. Its internet of things platform underpins both business-...
InteliCare Narrows Annual Loss and Turns Net Tangible Assets Positive
Aug 26, 2026
InteliCare Holdings Limited reported a reduced annual loss for the year ended 30 June 2026, with loss from ordinary activities after tax narrowing 6.5% to $2.10 million compared with the prior year. The company did not declare any dividends, and i...
InteliCare Says No Undisclosed News Behind Share Price Spike
Aug 25, 2026
InteliCare Holdings Ltd has responded to an Australian Securities Exchange price and volume query after its shares rose from $0.024 to an intraday high of $0.028 amid heavier trading. The company stated it is not aware of any undisclosed informati...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.